BUSINESS

BUSINESSMedicine

Anticancer(In Vitro)
  • Primary Cell-based Assay : Using target-oriented cell lines from a 96-well plate, anticancer effects are examined by MTT Assay or Sulforhodamine B.
  • Secondary Cell-based Assay : Kinetic studies on effects of drugs, studies on effects of drugs according to duration of exposure, studies on tolerance, studies on efficacy according to cell density, other studies of drug-cell interactions
Anticancer(In Vivo)
  • Tumor Model System (Xenograft Assay) : Anticancer effects are evaluated using nude mice, SCID mice, and mouse or human cell lines.
  • Resistance tumor model system : Anticancer effects are evaluated using internal tumor cell lines on nude and SCID mice.
  • Diabetes Evaluation of improvement in type 2 diabetes using C57BL/6J-db/db type 2 diabetes mouse models
  • Obesity Evaluation of improvement in obesity using C57BL/6J DIO (diet-induced obesity) mouse models
  • Arthritis Evaluation of improvement in rheumatoid arthritis using type 2 collagen-induced DBA/1J mouse models
  • Atopic Dermatitis Evaluation of improvement in atopic dermatitis using dermatophagoides farinae-induced NC/Nga mouse models
  • Hypertension Evaluation of improvement in hypertension using SHR (spontaneous hypertensive rat) models